ESC Professional Premium Access

Clinical outcomes and myocardial recovery in energetics, perfusion and contractile function after valve replacement surgery in severe aortic stenosis patients with diabetes comorbidity

Congress Session

About the speaker

Doctor Nicholas Jex

University of Leeds, Leeds (United Kingdom of Great Britain & Northern Ireland)
0 follower

6 more presentations in this session

Incidence and factors associated with de novo atrial fibrillation in patients with wild-type transthyretin cardiac amyloidosis

Speaker: Doctor C. Fumagalli (Florence, IT)

Thumbnail

Transthyretin cardiac amyloidosis in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement: a single center experience

Speaker: Doctor L. Scudeler (Turin, IT)

Thumbnail

NNC6019-0001, a humanized monoclonal antibody, in patients with transthyretin amyloid cardiomyopathy (ATTR-CM): rationale and study design of a phase 2, randomized, placebo-controlled trial

Speaker: Professor M. Fontana (London, GB)

Thumbnail

Change in echocardiography in patients with transthyretin amyloid cardiomyopathy with tafamidis treatment.

Speaker: Doctor M. Morioka (Kumamoto, JP)

Thumbnail

Valve disease in cardiac amyloidosis: an echocardiographic score

Speaker: Doctor A. Aimo (Pisa, IT)

Thumbnail

Access the full session

Amyloidosis and aortic stenosis

Speakers: Doctor N. Jex, Doctor C. Fumagalli, Doctor L. Scudeler, Professor M. Fontana, Doctor M. Morioka...
Thumbnail

About the event

Image

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

This platform is supported by

logo Novo Nordisk